Your session is about to expire
← Back to Search
Liraglutide for Type 1 Diabetes
Study Summary
This trial will test the effect of liraglutide, a long-acting glucagon-like peptide-1 analog, on blood sugar control in adolescents with Type 1 diabetes. Liraglutide is already approved for the treatment of Type 2 diabetes in adults.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2017 Phase 4 trial • 100 Patients • NCT02014740Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had surgery on my abdomen before.I have acid reflux.My diabetes is caused by steroids or cystic fibrosis.I use an insulin pump and a continuous glucose monitor.My family has a history of Multiple Endocrine Neoplasia 2B syndrome.I have previously used liraglutide.I have had pancreatitis before.You have a history of drinking a lot of alcohol or you don't want to stop drinking during the study.I have had thyroid cancer in the past.Your HbA1c level is less than 10%.I have been diagnosed with Type 1 Diabetes for over a year.I have a type of diabetes that requires insulin but is not caused by antibodies.
- Group 1: Liraglutide 0.6 mg
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are elderly individuals welcome to participate in this research?
"People who wish to apply for this trial must be aged between 15 and 21. Out of the 1223 similar trials, this is one of the few that includes people in this age range."
Are we still able to enroll patients in this research project?
"The clinical trial in question is not recruiting patients at this time, according to the information found on clinicaltrials.gov. This study was originally posted on 2012-05-01, and was last updated on 2022-03-07. Although this study is not searching for patients at this time, there are 1344 other studies actively looking for participants at this time."
Has Liraglutide been accepted by the FDA as a treatment option?
"Liraglutide has been through multiple rounds of clinical trials, so its safety has been well-documented. Our team gives it a score of 3."
What Liraglutide's common applications in medical treatment?
"Although often used as an exercise treatment, liraglutide can also help patients that have inadequate control on monotherapy, cardiovascular risk reduction, and cardiovascular disease (cvd)."
Might I be able to help out with this research project?
"This clinical trial is admitting 5 adolescent patients that have been diagnosed with type 1 diabetes mellitus for over a year. These individuals must also be currently using a continuous subcutaneous insulin infusion with continuous glucose monitoring device and have an HbA1c <10%."
How many subjects are being observed in this experiment?
"As of right now, this study is no longer looking for patients that match the given criteria. The study was first posted on 2012-05-01 and was last updated on 2022-03-07. However, there are presently 1308 studies actively recruiting patients with type 1 diabetes mellitus and 36 studies for Liraglutide that are still searching for participants."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger